What are Nanoelectronic Biosensors?

Nanoelectronic biosensors are nanostructured semiconducting materials aimed at addressing nanomolecules to facilitate appropriate solutions for biological activities at the cellular level. The past two decades have seen the emergence of research endeavors to empirically study the capability of nanoelectronic biosensors in medicine.

The emergence of nanoelectronic biosensors in current medical research was greatly influenced by research endeavors to merge electronics with medical interventions. Nowadays, there is a great need to treat medical conditions at the biomolecular and cellular levels; however, previous knowledge and techniques on medicine have been found to be inefficient in doing so. As such, machineries targeting the molecular level become a need. These bioelectronic mechanisms should offer high sensitivity to detect target molecules or minute signals, and appropriate spatial and temporal resolution for biological activities.

Nanoelectronic biosensors have an active conducting channel made up of nanostructured semiconducting (NS-SC) materials with their flow confined at the surface. Because of this, the materials become sensitive to electrical perturbations that occur during electrogenic biological activities or upon the interaction of biomolecules near the surface. The nanoscale dimensions of NS-SC materials are able to interact easily with the biomolecules because of their similar sizes.

How do Nanoelectronic Biosensors Work?

Nanoelectronic biosensors rely on the conductive properties of its material composition and their ability to send electric signals to a remote device. To ensure the efficiency of the sensor, nanowires with high conductivity are used. However, researchers in bioengineering and nanotechnology companies are striving to develop new nanoelectronic biosensors composed of a variety of material alternatives.

Nanoelectronic biosensors are administered by doctors to patients who are at risk for a particular disease. The sensor then relay signals and health status readings based on cellular activity. In doing so, the physician is easily able to monitor vital signs and symptoms which allow them to gain in-depth knowledge about the disease progression. Physicians are also be able to identify the location of diseases or malignant cell growths. Because of this, nanoelectronic biosensors could be used early on in accurately diagnosing patients, especially when the patient’s symptomatology leads to various diagnostic possibilities.

Uses of Nanoelectronic Biosensors

A variety of materials with specific configurations and sensing mechanisms could be used in the development of nanoelectronic biosensors. This paves the way for a large selection of biosensing targets and chemistries for biofunctionalization.

Nanoelectronic biosensors have been found to be effective primarily in detecting the presence of molecular and cellular functions at low levels of concentration. The detection of viruses and development of DNA-hybridization kinetics have also been made possible through emerging innovations in the field.

Nanoelectronic biosensors are also hypothesized to improve and revolutionize the current state of point-of-care medical diagnoses by allowing sensing mechanisms that are based on direct current conductance and ionic screening effects. Recent evidences have shown that the use of nanoelectronic biosensors in such manner positively affects the patients with medical conditions.

Advantages of Nanoelectronic Bbiosensors

In comparison with conventional techniques in medicine, nanoelectronic biosensors are more capable of targeting smaller molecules or cells, and showing more detailed cellular functions. Studies also show that nanoelectronic biosensors have the capacity to interfere with live cells and detect dynamic cellular activities. As such, the understanding and treatment of medical conditions become more promising because they may be treated at the cellular level with accuracy and consistency with the help of nanoelectronic biosensors.

The variety of nanoelectronic biosensing materials are also helpful in promoting a larger scope of treatment in the bioengineering sciences. While most nanoelectronic biosensors being used at present are based on charge detection, studies have now found that a different sensing mechanism based on molecular dipole detection could also improve the course of development of nanoelectronics in medicine. These trends show that nanoelectronic biosensors are capable of addressing various cellular interactions and are usable in the long-term prevention, identification, monitoring, or rectification of diseases.

Sources:

Further Reading

Last Updated: Feb 26, 2019

Gaea Marelle Miranda

Written by

Gaea Marelle Miranda

Gaea graduated from the University of the Philippines, Manila, with a degree in Behavioral Sciences, cum laude . Majoring in psychology, sociology, and anthropology, she approaches writing with a multidisciplinary perspective.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Miranda, Gaea Marelle. (2019, February 26). What are Nanoelectronic Biosensors?. News-Medical. Retrieved on December 12, 2019 from https://www.news-medical.net/health/What-are-Nanoelectronic-Biosensors.aspx.

  • MLA

    Miranda, Gaea Marelle. "What are Nanoelectronic Biosensors?". News-Medical. 12 December 2019. <https://www.news-medical.net/health/What-are-Nanoelectronic-Biosensors.aspx>.

  • Chicago

    Miranda, Gaea Marelle. "What are Nanoelectronic Biosensors?". News-Medical. https://www.news-medical.net/health/What-are-Nanoelectronic-Biosensors.aspx. (accessed December 12, 2019).

  • Harvard

    Miranda, Gaea Marelle. 2019. What are Nanoelectronic Biosensors?. News-Medical, viewed 12 December 2019, https://www.news-medical.net/health/What-are-Nanoelectronic-Biosensors.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Cooperative research center at LLNL aims to develop vaccines for chlamydia